Listed broking firms faced significant profit declines in the March quarter due to stricter regulations imposed by SEBI, including the scrapping of popular derivative products and reduced trading activity following a stock market downturn. These regulatory changes, such as uniform fee structures and true-to-label norms, impacted retail participation and increased transaction costs.
Pharma, Auto, and IT: Pankaj Pandey shares sectoral insights amid global challenges
Pankaj Pandey shares insights on Indian sectors facing US tariffs. He sees limited impact on pharma growth but potential benefits for Jubilant Pharma and Piramal